Pricing term insurance in the presence of a family history of breast or ovarian cancer

North American Actuarial Journal

Volumn 4, Issue 2, 2000, Pages 75-87

  Lemaire, Jean ^a   Subramanian, Krupa ^b   Armstrong, Katrina ^a   Asch, David A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84869872794     PISSN: 10920277     EISSN: None     Source Type: Journal    
DOI: 10.1080/10920277.2000.10595904     Document Type: Article

References (15)

1. American Cancer Society. 1992. Cancer Facts and Fiǵures. Atlanta.
2. Brackenridge, R. D. C., and Elder, W. J. 1998. Medical Selection of Life Risks. London: Macmillan.
3. Claus, E., Risch, N., and Thompson, W. D. 1990. "Aǵe at Onset as an Indicator of Familial Risk of Breast Cancer," American Journal of Epidemioloǵy 131:961–72.
4. Claus, E., Risch, N., and Thompson, W. D. 1994. "Autosomal Dominant Inheritance of Early-Onset Breast Cancer," Cancer 73:643–51.
5. Claus, E., et al. 1998. "Effect of BRCA1 and BRCA2 on the Association Between Breast Cancer Risk and Family History," Journal of the National Cancer Institute 90:1824–9.
6. Easton, D., et al. 1995. "Breast and Ovarian Cancer Incidence in BRCA1-Mutation Carriers," American Journal of Human Genetics 56:265–71.
7. Ford, D., et al. 1994. "Risks of Cancers in BRCA1 Mutation Carriers," Lancet 343:692–5.
8. Ford, D., Easton, D., and Peto, J. 1995. "Estimates of the Gene Frequency of BRCA1 and Its Contribution to Breast and Ovarian Cancer Incidence," American Journal of Human Genetics 57:1457–62.
9. Gail, M., et al. 1989. "Projectinǵ Individualized Probabilities of Developinǵ Breast Cancer for White Females Who Are Beinǵ Examined Annually," Journal of the National Cancer Institute 81:1879–86.
10. Hartge, P., et al. 1994. "Rates and Risks of Ovarian Cancer in Subǵroups of White Women in the United States," Obstetrics and Gynecoloǵy 84:760–4.
11. Lowden, J. A. 1998. "The Current State of Genetic Testinǵ in Life Insurance," In Genetic Testing: Implications for Insurance, 19–28. Schaumburg, Ill.: The Actuarial Foundation.
12. National Cancer Institute. 1995. SEER Cancer Statistics Review 1973–1995. Bethesda: National Institutes of Health.
13. Struewing, J., et al. 1997. "The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 amonǵ Ashkenazi Jews," New Enǵland Journal of Medicine 336: 1401–8.
14. Taylor, G. 1977. "Separation of Inflation and Other Effects from the Distribution of Non-Life Insurance Claim Delays," ASTIN Bulletin 9:219–30.
15. Wooster, R., et al. 1995. "Identification of the Breast Cancer Susceptibility Gene BRCA2," Nature 378:789–92.